4
Changes in Ownership
Greenwich LifeSciences, Inc. Filed Acc 0001493152-24-030473
CEO and CFO bought 5,500 shares at $13.18 ($72,490)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patel Snehal CEO and CFO | 2024-08-05 | Purchase | +5,500 | $13.18 | $72,490 | 5,532,602 | D |
| Open-market purchases · 5,500 sh · avg $13.18 · $72,490 | |||||||
Loading xslF345X05/ownership.xml…